Nivolumab and ipilimumab in the real-world setting in patients with mesothelioma. Dumoulin DW, Douma LH, Hofman MM, van der Noort V, et al. Lung Cancer 2024;187:107440.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dumoulin DW, Douma LH, Hofman MM, van der Noort V, et al. Nivolumab and ipilimumab in the real-world setting in patients with mesothelioma. Lung Cancer 2024;187:107440.
PMID: 38104353